Targeting PERK-ATF4-P21 axis enhances the sensitivity of osteosarcoma HOS cells to Mppα-PDT
Aging · 2024
DOI: 10.18632/aging.205511 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Shenxi Zhong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Yuzhong, Chongqing 400016, China. Hauptthemen laut MEDLINE: Osteosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Yuzhong, Chongqing 400016, China.
- Orthopedic Laboratory of Chongqing Medical University, Yuzhong, Chongqing 400016, China.
Zitieren
APA
Zhong, S., Zhang, Y., Mou, H., Jian, C., Huang, Q., & Ou, Y. (2024). Targeting PERK-ATF4-P21 axis enhances the sensitivity of osteosarcoma HOS cells to Mppα-PDT. Aging. https://doi.org/10.18632/aging.205511
Vancouver
Zhong S, Zhang Y, Mou H, Jian C, Huang Q, Ou Y. Targeting PERK-ATF4-P21 axis enhances the sensitivity of osteosarcoma HOS cells to Mppα-PDT. Aging. 2024. doi:10.18632/aging.205511
BibTeX
@article{Zhong2024,
author = {Zhong, Shenxi and Zhang, Ye and Mou, Hai and Jian, Changchun and Huang, Qiu and Ou, Yunsheng},
title = {Targeting PERK-ATF4-P21 axis enhances the sensitivity of osteosarcoma HOS cells to Mppα-PDT},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.205511}
}
EUVIMED